Abstract
The study aimed to examine the applicability of carbon nanoparticles as a tracer for lymph node mapping and the related factors of lymph node and No.8p subgroup metastasis in patients with gastric cancer. Clinical data of 50 patients with gastric cancer, who had not received treatment preoperatively and underwent gastrectomy in Department of Gastrointestinal Surgery, Wuhan Union Hospital, between October 2014 and August 2015, were retrospectively analyzed. These patients were found to have no distant metastasis preoperatively. Thirty-five out of 50 patients were subjected to lymphatic mapping technique using carbon nanoparticles as the tracer, and the rest 15 cases did not experience the lymphatic mapping and served as controls. The sensitivity, specificity, false positive rate and false negative rate were calculated according to the number of lymph nodes, and the staining and metastasis condition of lymph nodes. The diagnostic value of carbon nanoparticles on metastatic lymph nodes was evaluated. The relationship between the metastasis of lymph nodes or subgroup No.8p lymph nodes and clinicopathologic features was analyzed by χ2-test or Fisher’s exact test. All patients underwent D2 surgery (lymph node dissection including all the group 1 and group 2 nodes) plus the dissection of the subgroup No.8p lymph nodes. It was found that the average number of harvested lymph nodes in lymphatic mapping technique group (45.7±14.5) was greater than that in control group (39.2±11.7), but the difference was not significantly different (P=0.138>0.05). The success rate, the accuracy, sensitivity, specificity and false negative rate was 97%, 57%, 28%, 62% and 72% respectively. The metastasis of lymph nodes was correlated to the depth of cancer invasion (T stage) (P=0.004<0.05), and the metastasis of No.8p lymph nodes was correlated to the extent of lymph node involvement (N stage) (P=0.007<0.05). Six cases had lymph node metastasis in subgroup No.8p, and their TNM stages and clinical stages were as follows: T1N2M0 IIA, T3N3M0 IIIB, T4aN3M0 IIIC, T4aN3M0 IIIC, T4aN3M0 IIIC, and T4bN3M0 IIIC. In conclusion, our study indicated that carbon nanoparticles failed to show good selectivity for metastatic lymph nodes; the result of lymphatic mapping does not achieve a satisfactory performance; the incidence of lymph node metastasis may increase, accompanying with the increase of the depth of cancer invasion; No.8p lymph node metastasis tends to occur for gastric carcinoma patients with the extent of lymph node metastasis over N2 stage.
Similar content being viewed by others
References
Jemal A, Bray F, Center MM, et al. Global cancer statistics. Cancer J Clin, 2011,61(2):69–90
Dicken BJ, Bigam DL, Cass C, et al. Gastric Adenocarcinoma: Review and Considerations for Future Directions. Ann Surg, 2005,241(1):27–39
Tanizawa Y and Terashima M. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Gastric Cancer, 2010,13(3):137–148
Siewert JR, Böttcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg Oncol, 1998,228(4):449–461
Marubini E, Bozzetti F, Miceli R, et al. Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications. EJSO, 2002,28(4):406–412
Noguchi Y, Imada T, Matsumoto A, et al. Radical surgery for gastric cancer. A review of the Japanese experience. Cancer, 1989,64(10):2053–2062
Roviello F, Rossi S, Marrelli D, et al. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol, 2006,94(4):275–280; discussion 274
Abe N, Watanabe T, Suzuki K, et al. Risk factors predictive of lymph node metastasis in depressed early gastric cancer. Am J Surg, 2002,183(2):168–172
Bickenbach K, Strong VE. Comparisons of Gastric Cancer Treatments: East vs. West. J Gastric Cancer, 2012,12(2):55–62
Japanese Classification of Gastric Carcinoma 2nd English Edition. Gastric Cancer, 1998,1(1):10–24
Bonenkamp JJ, Hermans J, Sasako M, et al. Extended Lymph-Node Dissection for Gastric Cancer. N Engl J Med, 1999,340(12):908–914
Li C, Kim S, Lai JF, et al. Solitary lymph node metastasis in gastric cancer. J Gastrointest Surg, 2008,12(3):550–554
Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer, 2011,14(2):113–123
Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer, 2000,3(4):219–225
Kelder W, Nimura H, Takahashi N, et al. Sentinel node mapping with indocyanine green (ICG) and infrared ray detection in early gastric cancer: An accurate method that enables a limited lymphadenectomy. EJSO, 2010,36(6):552–558
Maruyama K, Gunvén P, Okabayashi K, et al. Lymph Node Metastases of Gastric Cancer: General Pattern in 1931 Patients. Ann Surg, 1989,210(5):596–602
Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer, 2011,14(2):101–112
Kosaka T, Ueshige N, Sugaya J, et al. Lymphatic routes of the stomach demonstrated by gastric carcinomas with solitary lymph node metastasis. Surg Today, 1999,29(8):695–700
Morton DL, Wen D, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg, 1992,127(4):392–399
Veronesi U, Paganelli G, Viale G, et al. A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer. N Engl J Med, 2003,349(6):546–553
Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA, 1996,276(22):1818–1822
Kitagawa Y, Fujii H, Mukai M, et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am, 2000,80(6):1799–1809
Takeuchi H, Kitagawa Y. Sentinel Node Navigation Surgery in Patients with Early Gastric Cancer. Dig Surg, 2013,30(2):104–111
Kinami S, Fujimura T, Ojima E, et al. PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flow. Int J Clin Oncol, 2008,13(4):320–329
Kitagawa Y, Takeuchi H, Takagi Y, et al. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol, 2013,31(29):3704–3710
Kitagawa Y, Kitano S, Kubota T, et al. Minimally invasive surgery for gastric cancer — toward a confluence of two major streams: a review. Gastric Cancer, 2005,8(2):103–110
Hiratsuka M, Miyashiro I, Ishikawa O, et al. Application of sentinel node biopsy to gastric cancer surgery. Surgery, 2001,129(3):335–340
Park DJ, Lee HJ, Lee HS, et al. Sentinel node biopsy for cT1 and cT2a gastric cancer. Eur J Surg Oncol, 2006,32(1):48–54
Miyashiro I. What is the problem in clinical application of sentinel node concept to gastric cancer surgery? J Gastric Cancer, 2012,12(1):7–12
Can MF, Yagci G, Cetiner S. Sentinel lymph node biopsy for gastric cancer: Where do we stand? World J Gastrointest Surg, 2011,3(9):131–137
Ohdaira H, Nimura H, Takahashi N, et al. The possibility of performing a limited resection and a lymphadenectomy for proximal gastric carcinoma based on sentinel node navigation. Surg Today, 2009,39(12):1026–1031
Takeuchi H and Kitagawa Y. New Sentinel Node Mapping Technologies for Early Gastric Cancer. Ann Surg Oncol, 2013,20(2):522–532
Hayashi H, Ochiai T, Mori M, et al. Sentinel lymph node mapping for gastric cancer using a dual procedure with dye-and gamma probe-guided techniques. J Am Coll Surg, 2003,196(1):68–74
Lee JH, Ryu KW, Nam BH, et al. Factors associated with detection failure and false-negative sentinel node biopsy findings in gastric cancer: Results of prospective single center trials. J Surg Oncol, 2009,99(3):137–142
Lee JS, Douglass HO. D2 dissection for gastric cancer. Surg Oncol, 1997,6(4):215–225
Author information
Authors and Affiliations
Corresponding author
Additional information
Both authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wang, H., Chen, Mm., Zhu, Gs. et al. Lymph node mapping with carbon nanoparticles and the risk factors of lymph node metastasis in gastric cancer. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 36, 865–870 (2016). https://doi.org/10.1007/s11596-016-1676-6
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-016-1676-6